UCB emerged as a major biopharmaceutical player in the 1990s with the development of blockbuster drugs Zyrtec and Keppra. Throughout the 1990s and early 2000s, UCB transformed from a hybrid ...

“I was surprised to learn that formulations of epinephrine were available with different indications yet overlapping labels,” he added. The takeaway for clinicians is that the FDA is doing its ...